Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas.
about
Current treatment of rectal cancer adapted to the individual patientClinical application of multimodality imaging in radiotherapy treatment planning for rectal cancerLocally advanced gastroesophageal junction tumor: a treatment dilemmaIntensity-modulated radiation therapy for rectal carcinoma can reduce treatment breaks and emergency department visitsIntensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series.Volumetric modulated arc therapy (VMAT) in the combined modality treatment of anal cancer patientsFive fractions of radiation therapy followed by 4 cycles of FOLFOX chemotherapy as preoperative treatment for rectal cancer.Anal adenocarcinoma requires prophylactic inguinal nodal treatment: Results from a single Chinese institutionFDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma.Technical aspects of radiation therapy for anal cancer.Dosimetric coverage of the external anal sphincter by 3-dimensional conformal fields in rectal cancer patients receiving neoadjuvant chemoradiation: implications for the concept of sphincter-preserving radiation therapy.Bone marrow tolerance during postoperative chemotherapy in colorectal carcinomas.Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting.Nanotechnology in radiation oncology.IMRT, RapidArc® and conformal radiotherapy in the treatment of tumours of the anal canal.VMAT planning study in rectal cancer patientsRTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canalInterstitial high-dose rate brachytherapy as boost for anal canal cancer.Radiation therapy of anal canal cancer: from conformal therapy to volumetric modulated arc therapyConsequences of anorectal cancer atlas implementation in the cooperative group setting: radiobiologic analysis of a prospective randomized in silico target delineation study.Thymidylate synthase genotype-directed neoadjuvant chemoradiation for patients with rectal adenocarcinoma.Is elective inguinal radiotherapy necessary for locally advanced rectal adenocarcinoma invading anal canal?Tools for consensus analysis of experts' contours for radiotherapy structure definitions.Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinomaCAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer.Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer.NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer.Predictive value of APAF-1 and COX-2 expression in pathologic complete response to neoadjuvant chemoradiotherapy for patients with locally advanced rectal adenocarcinoma.Clinical results and toxicity for short-course preoperative radiotherapy and total mesorectal excision in rectal cancer patients.Estimation of second cancer risk after radiotherapy for rectal cancer: comparison of 3D conformal radiotherapy and volumetric modulated arc therapy using different high dose fractionation schemes.Proposed genitalia contouring guidelines in anal cancer intensity-modulated radiotherapy.Neoadjuvant radiation therapy prior to total mesorectal excision for rectal cancer is not associated with postoperative complications using current techniques.Stereotactic body radiation therapy for abdominal oligometastases: a biological and clinical review.ACR appropriateness criteria® resectable rectal cancerContrast media use in radiation oncology: a prospective, controlled educational intervention study with retrospective analysis of patient outcomesComparison of bone marrow sparing intensity modulated radiotherapy (IMRT) and three-dimensional conformal radiotherapy (3DCRT) in carcinoma of anal canal: a prospective study.Genital invasion or perigenital spread may pose a risk of marginal misses for Intensity Modulated Radiotherapy (IMRT) in anal cancerPredictors of acute toxicities during definitive chemoradiation using intensity-modulated radiotherapy for anal squamous cell carcinoma.Sphincter preservation in anal cancer: a brief review.Dosimetric impact of inter-observer variability for 3D conformal radiotherapy and volumetric modulated arc therapy: the rectal tumor target definition case.
P2860
Q26824553-4ECF334C-8B15-450F-B38A-5A7EC5C4F0DCQ27005702-95F03EAC-22A4-4107-8026-2025FBFA5461Q28082596-D2338C73-BF34-4E5E-A6FF-4EE89DF1CC55Q30425396-B391956C-50BA-4FAC-897F-E75B4C1E8A22Q33422634-EF5E61DA-BF08-49FE-B71D-8442E276E6A2Q33429717-A7B8116D-3797-4DA0-9064-E507F5B21AF5Q33637997-61D38D8E-1248-4D2F-84CE-954DF8783012Q33702377-E813F410-7D58-44C7-9BAC-6E06DEB4C6FFQ33776972-FFA122C8-AE23-4E42-AF81-293D6FA3B306Q33820797-1579CF18-2C8F-45E7-8F03-4F58F868A564Q33893811-587FD6B9-FEEE-4FD1-B760-DAF69CC88E8FQ33895624-5ADCEF6A-B615-49D4-B22E-5ED722342E9EQ34088596-6BF00FDB-BDFE-4A67-A263-201A7A21323BQ34124280-5A317B5C-FE0B-4621-AC65-09014FF8A668Q34372829-256F4922-B638-47FE-A724-0B91FD791437Q34381925-E874DE1E-07E7-4331-B710-2625D9F4191EQ34478729-4B04BE85-3EEB-493D-BFEA-64FD6CE27DF7Q34499551-581AAC04-EFBB-4661-BBB3-1211F08CBD28Q34584811-B16824B9-7265-44CC-9F44-0500CA152C68Q34643927-5D27F9B6-166E-4351-BE07-36D44E7FF054Q34743494-6BF858FC-2077-47A6-A396-6B8BBE83DA9FQ34987373-8C19C768-1576-404C-9E95-9F8AA40249DDQ35048872-CE67CD50-672A-4754-85DB-E3C3408BDACAQ35063720-A10C2593-4CB2-4798-A971-A22149FCB59DQ35158553-17FC89EE-F65B-485D-B8FA-F8ADB1EB500BQ35623320-08AEBB0F-FDCC-405E-8820-E64EFB9B7038Q35967483-296503E4-B716-4690-9914-7FE0449E03C4Q36011044-5B898518-7A2A-420F-90F8-8ED5A7EF6B62Q36067009-12CB6938-B768-4336-8ECE-E49EA932237DQ36189255-B46C337B-443B-4F15-AA3F-4632AB8D1E9DQ36235721-1302FB3C-C13A-434D-A1EB-2A60043E4BC8Q36246949-1A4345E4-51C0-4419-9D4B-D2AD8B199170Q36360066-8A5259DA-2596-4723-9BA3-1717374312D4Q36371152-98B73D05-DC25-4A2D-918E-F03699B902F9Q36468039-637800F3-43DD-4FA8-975B-02C89020F096Q36656107-3A64E1BD-2F50-4FDE-AAFD-A446C8C51798Q36765574-98DAC48A-F22D-4E39-A3E0-E354FC5CB175Q36770084-60B57949-1A63-4C5C-A9D4-FB322D60FC02Q37005884-4473BAFE-BBD7-4419-AAFE-AB00318B85E8Q37038061-53EA1FED-E194-4963-BEEE-54711B8D1F77
P2860
Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Elective clinical target volum ...... sensus panel contouring atlas.
@en
Elective clinical target volum ...... sensus panel contouring atlas.
@nl
type
label
Elective clinical target volum ...... sensus panel contouring atlas.
@en
Elective clinical target volum ...... sensus panel contouring atlas.
@nl
prefLabel
Elective clinical target volum ...... sensus panel contouring atlas.
@en
Elective clinical target volum ...... sensus panel contouring atlas.
@nl
P2093
P2860
P1476
Elective clinical target volum ...... nsensus panel contouring atlas
@en
P2093
Aditya Apte
Christopher G Willett
J J John Kim
Leonard L Gunderson
Lisa A Kachnic
Michael C Garofalo
Prajnan Das
Robert J Myerson
Ross A Abrams
Theodore S Hong
P2860
P304
P356
10.1016/J.IJROBP.2008.08.070
P407
P577
2008-12-29T00:00:00Z